MitapivatA Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

Sponsor:

Agios Pharmaceuticals, Inc.

Code:

NCT07656415

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Mitapivat Matched Placebo

Mitapivat

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by Agios Pharmaceuticals, Inc. on 2026-08-04.